These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39048170)

  • 1. Timing of Histological Distal Villous Fetal Vascular Malperfusion in the Placenta: Clinical Significance and Placental Features.
    Stanek J
    Ann Clin Lab Sci; 2024 May; 54(3):289-298. PubMed ID: 39048170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of the Large Fetal Vessel Lesions in Placental Fetal Vascular Malperfusion.
    Stanek J
    Lab Invest; 2024 Jul; 104(7):102089. PubMed ID: 38810837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34 immunostain increases the sensitivity of placental examination for distal fetal vascular malperfusion in liveborn infants.
    Stanek J
    Placenta; 2023 Sep; 140():117-124. PubMed ID: 37573725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental CD34 immunohistochemistry in fetal vascular malperfusion in stillbirth.
    Stanek J; Drach A
    J Obstet Gynaecol Res; 2022 Mar; 48(3):719-728. PubMed ID: 35092332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal villous lesions are clinically more relevant than proximal large muscular vessel lesions of placental fetal vascular malperfusion.
    Stanek J
    Histol Histopathol; 2022 Apr; 37(4):365-372. PubMed ID: 34939657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental recent/on-going foetal vascular malperfusion with endothelial fragmentation is diagnostically equivalent to established distal villous lesions of foetal vascular malperfusion.
    Stanek J
    Pol J Pathol; 2022; 73(3):198-207. PubMed ID: 36734434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 immunostain increases the sensitivity of placental diagnosis of fetal vascular malperfusion in stillbirth.
    Stanek J; Abdaljaleel M
    Placenta; 2019 Feb; 77():30-38. PubMed ID: 30827353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal heterogeneity of placental segmental fetal vascular malperfusion: timing but not etiopathogenesis.
    Stanek J
    Virchows Arch; 2021 May; 478(5):905-914. PubMed ID: 32918597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmental villous mineralization: A placental feature of fetal vascular malperfusion.
    Stanek J
    Placenta; 2019 Oct; 86():20-27. PubMed ID: 31358342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 immunostain increases sensitivity of the diagnosis of fetal vascular malperfusion in placentas from ex-utero intrapartum treatment.
    Stanek J
    J Perinat Med; 2021 Feb; 49(2):203-208. PubMed ID: 32903209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental fetal vascular malperfusion in congenital diaphragmatic hernia.
    Stanek J
    Virchows Arch; 2024 Jan; 484(1):83-91. PubMed ID: 37439836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Umbilical Artery Umbilical Cord Is Associated With High-Grade Distal Fetal Vascular Malperfusion.
    Stanek J
    Pediatr Dev Pathol; 2024; 27(1):52-58. PubMed ID: 37771135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord compromise versus other clinical conditions predisposing to placental fetal vascular malperfusion.
    Stanek J
    Placenta; 2022 Sep; 127():8-11. PubMed ID: 35921763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental delayed villous maturation is associated with fetal congenital heart disease.
    O'Hare CB; Mangin-Heimos KS; Gu H; Edmunds M; Bebbington M; Lee CK; He M; Ortinau CM
    Am J Obstet Gynecol; 2023 Feb; 228(2):231.e1-231.e11. PubMed ID: 35985515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of placental injury in various types of fetal congenital heart disease.
    Stanek J
    J Perinat Med; 2023 Jun; 51(5):704-711. PubMed ID: 36573345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between fetal vascular malperfusion and gestational diabetes.
    Goto T; Sato Y; Kodama Y; Tomimori K; Sameshima H; Aman M; Maekawa K; Yamashita A; Asada Y
    J Obstet Gynaecol Res; 2022 Jan; 48(1):80-86. PubMed ID: 34729872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta in intrauterine fetal demise (IUFD): a comprehensive study from a tertiary care hospital.
    Manocha A; Ravikumar G; Crasta J
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3939-3947. PubMed ID: 29792056
    [No Abstract]   [Full Text] [Related]  

  • 19. The Placenta in Neonatal Encephalopathy: A Case-Control Study.
    Vik T; Redline R; Nelson KB; Bjellmo S; Vogt C; Ng P; Strand KM; Nu TNT; Oskoui M
    J Pediatr; 2018 Nov; 202():77-85.e3. PubMed ID: 30369428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stillbirths with placental hemorrhagic endovasculitis: a morphologic assessment with clinical implications.
    Sander CM; Gilliland D; Richardson A; Foley KM; Fredericks J
    Arch Pathol Lab Med; 2005 May; 129(5):632-8. PubMed ID: 15859634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.